# Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)

> **NCT01306578** · NA · COMPLETED · sponsor: **Mansoura University Children Hospital** · enrollment: 41 (actual)

## Conditions studied

- Guillain Barre Syndrome

## Interventions

- **DRUG:** IVIG
- **PROCEDURE:** Plasma Exchange

## Key facts

- **NCT ID:** NCT01306578
- **Lead sponsor:** Mansoura University Children Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-12
- **Final completion:** 2010-02
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2011-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306578, "Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01306578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*